The size of the Flow Cytometry market in Europe has been estimated at USD 1263.85 Million in 2021. It is projected to reach USD 2026.21 Million by 2026, at a CAGR of 9.9% during the forecast period.
Flow cytometry is widely utilized in cancer and immunodeficiency diagnosis. The flow cytometry market in Europe is projected to be driven by the rising prevalence of various diseases throughout the forecast period. The European Flow cytometry market is further projected to be fuelled by the increasing prevalence of targeted diseases. Also, the rising awareness towards health concerns and increasing chromosomal defects are expected to influence the market growth.
In addition, the proliferation of chronic and contagious diseases and the recent global pandemic is uplifting the market growth during the forecast period. The introduction of new flow cytometry technologies is expected to enhance the market growth. Furthermore, in the forecast period, product innovation in diagnostic reagents, extensive applications of flow cytometry in clinical research, stem cell research, and increasing technical improvement in the area of flow cytometry is expected to accelerate the market's growth.
The regional market players play an essential part in developing technologies for innovative instruments to enhance customer satisfaction, which has shown to help lead the fastest market growth and obtain a prominent share in the coming years. Growing awareness about a cancer diagnosis will likely create attractive growth opportunities for the flow cytometry market during the projected period. Furthermore, the adverse effects of chemotherapy and radiation therapy in cancer treatment have increased physicians' preference for autologous and allogeneic stem cell treatments, which is expected to boost the market's growth.
However, the lack of awareness among the potential users and the dearth of skilled professionals are expected to hinder the market growth. Also, the high cost associated with the instruments and reagents is expected to impede market growth.
This research report on the European Flow Cytometry market has been segmented and sub-segmented into the following categories:
Regionally, the European flow cytometry market held the second-largest share in the global market during the forecast period. Advances have mostly influenced the use of flow cytometry in immunology and other areas of cancer research. Although end-users, academics, and research institutes account for the majority of the market and are growing at the fastest rate due to flow cytometry, researchers are aided in various ways, including the rapid examination of various individual cell types within a population of cells suspended in fluid. The most well-known use of flow cytometry is immunophenotyping or the classification of cell subpopulations based on differentiation antigens. The major growth contributors in the region are UK, Germany, and France.
The German flow cytometry market accounted for the largest share of the flow cytometry market and likely continue its growth throughout the forecast period. The market growth is attributed to the availability of advanced technology and increasing healthcare spending. However, increasing the focus of the key market players for adopting effective strategies and policies to gain a competitive advantage over the marketplace is expected to expand the market growth.
On the other hand, the UK flow cytometry market is likely to anticipate the highest share in the flow cytometry market and expand the European regional market growth. The increasing prevalence of diseases such as cancer and HIV are majorly driving the market growth. Furthermore, high-performance flow cytometers and high-speed cell sorters are widely used in research fields such as HIV, cancer, stem cell, and drug development, propelling the market's growth. As a result, it is predicted that the flow cytometry market is predicted to grow more effectively throughout the forecasted period.
KEY MARKET PLAYERS:
A few of the companies playing a significant role in the Europe Flow Cytometry Market profiled in this report are Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc. and Affymetix Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.4 Y-o-Y Growth Analysis, By Technology
5.1.5 Market Attractiveness Analysis, By Technology
5.1.6 Market Share Analysis, By Technology
5.2.2 Reagents & Consumables
5.2.3 Flow Cytometry Instruments
22.214.171.124 Cell Analyzers
126.96.36.199 Cell Sorters
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
5.3.2 Research Applications
188.8.131.52 Pharmaceutical & Biotechnology
184.108.40.206 Cell Cycle Analysis
220.127.116.11 Cell Sorting
18.104.22.168 Cell Viability
22.214.171.124 Other Research Applications
5.3.3 Clinical Applications
126.96.36.199 Immunodeficiency Diseases
188.8.131.52 Organ Transplantation
184.108.40.206 Other Clinical Applications
5.3.4 Industrial Applications
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.3.2 Commercial Organizations
5.3.4 Academic Institutions & Medical Schools
5.3.5 Clinical Testing Labs
5.3.6 Research Institutes
5.3.7 Y-o-Y Growth Analysis, By End-users
5.3.8 Market Attractiveness Analysis, By End-users
5.3.9 Market Share Analysis, By End-users
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Technology
22.214.171.124 By Product
126.96.36.199 By Application
188.8.131.52 By End-users
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Technology
18.104.22.168 By Product
22.214.171.124 By Application
126.96.36.199 By End-users
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Technology
220.127.116.11 By Product
18.104.22.168 By Application
22.214.171.124 By End-users
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton, Dickinson and Company
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Beckman Coulter, Inc.
8.3 Thermo Fisher Scientific, Inc.
8.4 Merck KGaA
8.5 Sysmex Partec GmbH
8.6 Luminex Corporation
8.7 Miltenyi Biotec GmbH
8.8 Bio-Rad Laboratories, Inc.
8.9 Sony Biotechnology
8.10 Life Technologies Corporation Inc.
8.11 EMD Millipore Corporation
8.12 Miltenyi Biotec
8.13 Thermo Fischer Scientific
8.14 Agilent Technologies, Inc.
8.15 Affymetix Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures